Drugs ban: Partial relief from HC for Wockhardt,Glaxo & Griffon
Delhi High Court today stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
Mar 18, 2016, 16:13 PM IST